Masumoto and his team at RIKEN BDR have been looking for ways to slow down metabolism without inducing hypothermia. We know that many animals—such as bears and squirrels—can hibernate, and that despite the extremely slow metabolism during hibernation, they are healthy when they wake up. However, like most animals, people do not hibernate. This was the end of the story until a few years ago when Sunagawa’s group discovered a way to induce a hibernation-like state in mice—animals that do not normally hibernate. “If we can induce them, there are many possibilities for using hibernation-like states in cardiovascular medicine, resuscitation medicine, or other cases in which organ protection via hypothermia is insufficient or inappropriate,” says Sunagawa.
But first, the technique’s effectiveness needs to be verified in animal models. The new study is the first clinical implementation of the technique, and tested its effectiveness using a mouse model of aortic surgery that requires circulatory arrest. The team’s previous studies showed that hibernation-level hypometabolism could be achieved by activating special neurons in the brain’s hypothalamus called Q neurons. Chemogenetic biotechnology allowed the researchers to trigger activation of these specific neurons with an injection. They compared four groups of model mice that varied in whether or not cold temperatures were used to induce hypometabolism and whether or not Q neurons were activated.
Kidney damage and renal function were evaluated by looking at levels of biomarkers in the blood. Analysis showed hypometabolism induced by Q-neurons at normal temperatures protected the kidneys as well as that induced using hypothermia. “With these results, we now know that Q neurons ¬induced hibernation-like states can be used to protect organs,” says Masumoto.
The ultimate goal of Masumoto and Sunagawa’s research is to slow down people’s metabolism during heart surgery, or for other medical reasons, using some variation of this technique. But because Q neurons in people cannot be selectively activated the way they can in experimentally engineered mice, the team is now looking at ways to protect organs downstream from the brain. “Activating Q neurons triggers some sequence of biological events that allows organs to exist in a hypometabolic state for days,” explains Sunagawa. “Once we know precisely what these events are, we are confident we can induce them pharmacologically in the body, without needing to first activate the Q neurons.”
